Anti-Trichomonas vaginalis activity of betulinic acid derivatives

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Dariana Pimentel Gomes HübnerTiana Tasca

Abstract

Caused by Trichomonas vaginalis, trichomoniasis is the most common non-viral STD worldwide. Currently, metronidazole and tinidazole are the only drugs approved for treatment of the condition. However, problems such as metronidazole-resistant T. vaginalis isolates and allergic reactions have been reported. Based on data previously published by our group, structural changes in betulinic acid (1) were performed, generating three new compounds that were tested for in vitro anti-T.vaginalis activity in this study. Whereas derivative 2 did not demonstrate anti-T. vaginalis activity, derivatives 3 and 4 reduced trophozoite viability by 100%, with MIC values of 50μM. The structural difference of two compounds was performed only on the C-28 position. Derivative 3 showed low cytotoxicity against Vero cells in 24h; however, derivative 4 was highly cytotoxic, but efficient when associated with metronidazole in the synergism assay. ROS production by neutrophils was reduced, and derivative 3 showed anti-inflammatory effect. Collectively, the results of this study provide in vitro evidence that betulinic acid derivatives 3 and 4 are potential compounds with anti-T. vaginalis activity.

References

Aug 1, 1997·Planta medica·P K MukherjeeB P Saha
Apr 27, 2000·Sexually Transmitted Diseases·J N Krieger
Jul 18, 2000·Phytochemistry·C BoonlaksiriY Thebtaranonth
Apr 20, 2002·Current Opinion in Infectious Diseases·Michael W. Lehker, John F Alderete
Mar 8, 2003·Zeitschrift Für Naturforschung. C, a Journal of Biosciences·Girma M WoldemichaelBarbara N Timmermann
Dec 4, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Dimitrios P Kontoyiannis, Russell E Lewis
Oct 19, 2004·Clinical Microbiology Reviews·Jane R Schwebke, Donald Burgess
Mar 26, 2005·Current Medicinal Chemistry·Perumal Yogeeswari, Dharmarajan Sriram
May 17, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Siobhan SutcliffeElizabeth A Platz
May 23, 2006·Anti-cancer Agents in Medicinal Chemistry·Rama MukherjeeAnand C Burman
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Arlene C SeñaMyron S Cohen
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Madeline SuttonLauri Markowitz
Feb 12, 2009·European Journal of Medicinal Chemistry·Emanuel Hernández-NúñezGabriel Navarrete-Vazquez
Oct 24, 2009·Journal of Reproductive Immunology·Raina N Fichorova
Nov 27, 2009·Archives of Gynecology and Obstetrics·Jean-Christophe NoëlCorinne Engohan-Aloghe
Aug 3, 2010·Bioorganic & Medicinal Chemistry·Carlos Nava-ZuazoGabriel Navarrete-Vazquez
Mar 29, 2011·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Djana F Harp, Indrajit Chowdhury
Aug 23, 2011·Bioorganic & Medicinal Chemistry Letters·Keduo QianKuo-Hsiung Lee
Nov 30, 2011·Antioxidants & Redox Signaling·Chinmay Pal, Uday Bandyopadhyay
Jan 6, 2012·Parasitology Research·Tábitha Dahmer RochaGrace Gosmann
Oct 23, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Adrine Maria InnocenteSimone C B Gnoatto
Dec 4, 2012·Experimental Parasitology·Marina ScopelAlexandre José Macedo
Dec 12, 2012·Trends in Parasitology·Melissa D ConradJane M Carlton
Jun 8, 2013·Sexually Transmitted Infections·Danielle N Poole, R Scott McClelland
Oct 22, 2013·Chemical Biology & Drug Design·Adrine Maria InnocenteSimone C B Gnoatto
May 9, 2014·The American Journal of Tropical Medicine and Hygiene·W Evan SecorKimberly A Workowski
Jun 2, 2014·Parasitology Research·Adrine Maria InnocenteTiana Tasca
Oct 14, 2014·Tropical Medicine & International Health : TM & IH·Gloria N S SilvaSimone C B Gnoatto
Mar 20, 2015·Parasitology Research·Patrícia de Brum VieiraTiana Tasca
May 17, 2015·BMJ : British Medical Journal·Jeanne Lenzer

Citations

Dec 20, 2019·Parasitology Research·Raquel Nascimento das NevesSibele Borsuk
Feb 26, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yuqin YangHaimin Lei
Sep 11, 2020·BMC Complementary Medicine and Therapies·Mendel FriedmanKirkwood M Land
Jan 16, 2020·Acta Parasitologica·Laura Führich FabresMarilise Brittes Rott

Related Concepts

Betulinic acid
Metazoa
Schizonticides
Cercopithecus tantalus
Medicinal Plants Testing, Preclinical
HeLa Cells
Hemolysis
Fungus Drug Sensitivity Tests
Neutrophil Band Cells
Parasites

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

© 2021 Meta ULC. All rights reserved